Clinical Trial Update: A Multi-center, Ambispective Cohort Study to Evaluate the Impact of Iptacopan for Adult Patients With PNH in China

View source ↗

Summary

A multi-center ambispective cohort study in China evaluating the impact of iptacopan for adults with paroxysmal nocturnal hemoglobinuria. The trial is sponsored…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Nocturnal Hemoglobinuria

Drugs mentioned

• iptacopan (iptacopan)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Paroxysmal Nocturnal Hemoglobinuria | Status: RECRUITING